|
Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia |
|
|
|
Titel: |
Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia |
Auteur: |
Solaymani-Dodaran, Masoud Ghanei, Mostafa Bagheri, Mehdi Qazvini, Ali Vahedi, Ensieh Hassan Saadat, Seyed Amin Setarehdan, Seyed Ansarifar, Akram Biganeh, Hossein Mohazzab, Arash Khalili, Davood Hosein Ghazale, Amir Reza Heidari, Mohammad Taheri, Ali Khoramdad, Maliheh Mahdi Asadi, Mohammad Nazemieh, Masoud Varshochi, Mojtaba Abbasian, Samaneh Bakhtiari, Ali Mosaed, Reza Hosseini-shokouh, Seyyed-Javad Shahrokhi, Masoume Yassin, Zeynab Ali Zohal, Mohammad Qaraati, Maryam Rastgoo, Nafiseh Sami, Ramin Javad Eslami, Mohammad Asghari, Akram Namazi, Mansoor Ziaie, Shadi Jafari-Moghaddam, Raana Kalantari, Saeid Memarian, Mohammad Khodadadi, Javad Hossein Afshari, Mohammad Momen-Heravi, Mansooreh Behzadseresht, Niusha Reza Mobayen, Ahmad Mozafari, Abolfazl Movasaghi, Fatemeh Haddadzadeh Shoushtari, Maryam Moazen, Javad |
Verschenen in: |
International immunopharmacology |
Paginering: |
Jaargang 95 () nr. C pagina's p. |
Jaar: |
2021 |
Inhoud: |
|
Uitgever: |
Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|